Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Clinical trial NCT00720356 · COMPLETED
Trial details
- NCT number
- NCT00720356
- Sponsor
- Northwestern University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-07
- Primary completion
- 2014-06-24
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.